Foundation Fighting Blindness

Science

Latest episode

242 episodes

Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy
2025/12/18 | 2 mins.
The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.
Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara
2025/12/05 | 43 mins.
Dr. Deniz Dalkara, a research director at INSERM in France, talks to hose Ben Shaberman about her emerging gene-agnostic, gene therapy designed to restore cone-mediated vision in people with advanced retinitis pigmentosa. Known as SPVN20 and clinically developed by SparingVision, the treatment recently moved into a clinical trial in Europe. Dr. Dakara also discusses her earlier work in retinal gene and optogenetic therapy development.
Belite Bio to Seek FDA Approval for its Stargardt Disease Drug
2025/12/02 | 3 mins.
Tinlarebant slowed disease progression by 36 percent in the Dragon Phase 3 clinical trial.
Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease
2025/11/14 | 2 mins.
The Foundation funded preclinical studies for the approach and launched Opus.
Eye on the Cure Podcast | Episode 95: Greta Streimikyte
2025/11/14 | 20 mins.
Greta Streimikyte, a blind para-athletic running champion from Ireland, talks to host Ben Shaberman about growing up with substantial vision loss from retinopathy of prematurity and her competitive running career. Greta has won gold in the women's 1500 meters at the 2018 and 2021 European Para Athletic Championships and is a three-time Paralympian.

More Science podcasts

About Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

Podcast website

Science